Kategorien
Aktien

Merck & Co. 77,17 USD -0,43% 

Aktionärsstruktur der Merck & Co.

317 News & Informationen zur Merck & Co. Aktie

  • Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline is Expected to Support Growth - Forecast to 2027
    prnewswire.com

    Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline is Expected to Support Growth – Forecast to 2027

    /PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By…

  • Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline Is Expected To Support Growth - Forecast To 2027
    thestreet.com

    Global Respiratory Syncytial Virus Market 2021: Strong Product Pipeline Is Expected To Support Growth – Forecast To 2027

    DUBLIN, Aug. 31, 2021 /PRNewswire/ — The “Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form

  • Pete Najarian Sees Unusual Options Activity In Merck And FXI
    benzinga.com

  • Nabriva Therapeutics To Present At The H.C. Wainwright 23rd Annual Global Investment Conference
    thestreet.com

    Nabriva Therapeutics To Present At The H.C. Wainwright 23rd Annual Global Investment Conference

    DUBLIN, Ireland and FORT WASHINGTON, Pa., Aug. 31, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc NBRV, a biopharmaceutical company engaged in the

  • FDA Approves Updated Indication For Merck's KEYTRUDA® (pembrolizumab) For Treatment Of Certain Patients With Urothelial Carcinoma (Bladder...
    thestreet.com

    FDA Approves Updated Indication For Merck's KEYTRUDA® (pembrolizumab) For Treatment Of Certain Patients With Urothelial Carcinoma (Bladder Cancer)

    Merck MRK, known as MSD outside the United States and Canada, today announced a label update for KEYTRUDA, Merck's anti-PD-1 therapy, for its indication in

  • Biotech Takeovers Moved at Snail's Pace in 2nd Quarter
    gurufocus.com

    Biotech Takeovers Moved at Snail's Pace in 2nd Quarter

    GuruFocus Article or News written by Barry Cohen and the topic is about: Total value of deals was only $3.2 billion

  • Pfizer's Covid Technology May Have Cancer Applications
    gurufocus.com

    Pfizer's Covid Technology May Have Cancer Applications

    GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers

  • MetLife Investment Management : and Norges Bank Investment Management Announce $825.1 Million Acquisition of One Memorial Drive
    marketscreener.com

    MetLife Investment Management : and Norges Bank Investment Management Announce $825.1 Million Acquisition of One Memorial Drive

    Largest single-asset office transaction in the U.S. market for 2021
    … | August 26, 2021

  • 5 Penny Stocks Insiders Are Buying
    benzinga.com

    5 Penny Stocks Insiders Are Buying

    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in …

  • After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?
    forbes.com

    After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?

    The stock price of Pfizer reached an all-time high of $52 last week before a recent sell-off in Covid-19 vaccine stocks drove PFE down to its current level of around $48. PFE stock has fallen 4% over the last five days. The decline was seen in other Covid-19 vaccine stocks as well…

  • Outlook On The Multiple Myeloma Drugs Global Market To 2026 - By Therapy, Drug Type, End-user, Distribution Channel And Region
    thestreet.com

    Outlook On The Multiple Myeloma Drugs Global Market To 2026 – By Therapy, Drug Type, End-user, Distribution Channel And Region

    DUBLIN, Aug. 25, 2021 /PRNewswire/ — The “Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”

  • Global Antidiabetic Drug Market Report 2021-2026 - Opportunities in New Innovations
    prnewswire.com

    Global Antidiabetic Drug Market Report 2021-2026 – Opportunities in New Innovations

    /PRNewswire/ — The “Global Antidiabetic Drug Market (2021-2026) by Drug Type, Diabetic Type, Patient, Geography, Competitive Analysis and the Impact of…

  • ANTIPODES PARTNERS Ltd Buys Frontier Communications Parent Inc, Oracle Corp, PagerDuty Inc, Sells General Electric Co, Wells Fargo,...
    gurufocus.com

    ANTIPODES PARTNERS Ltd Buys Frontier Communications Parent Inc, Oracle Corp, PagerDuty Inc, Sells General Electric Co, Wells Fargo, AmerisourceBergen Corp

    GuruFocus Article or News written by insider and the topic is about:

  • Orbimed Advisors Llc Buys SPDR Biotech ETF, NeuroPace Inc, Janux Therapeutics Inc, Sells Haemonetics Corp, AbCellera Biologics Inc, Adverum...
    gurufocus.com

    Orbimed Advisors Llc Buys SPDR Biotech ETF, NeuroPace Inc, Janux Therapeutics Inc, Sells Haemonetics Corp, AbCellera Biologics Inc, Adverum Biotechnologies Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global Dermatology Drugs Market to 2027 - Industry Analysis, Trends, Market Size, and Forecasts
    prnewswire.com

    Global Dermatology Drugs Market to 2027 – Industry Analysis, Trends, Market Size, and Forecasts

    /PRNewswire/ — The “Dermatology Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to…

  • Global Companion Diagnostics Market Report 2021-2027: Broader Scope and Applications Rev Up Growth Opportunities
    prnewswire.com

    Global Companion Diagnostics Market Report 2021-2027: Broader Scope and Applications Rev Up Growth Opportunities

    /PRNewswire/ — The

  • Global Companion Diagnostics Market Report 2021-2027: Broader Scope And Applications Rev Up Growth Opportunities
    thestreet.com

    Global Companion Diagnostics Market Report 2021-2027: Broader Scope And Applications Rev Up Growth Opportunities

    DUBLIN, Aug. 24, 2021 /PRNewswire/ — The

  • Looking for Healthier Healthcare Stocks?
    etftrends.com

    Looking for Healthier Healthcare Stocks?

    The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs.

  • Looking for a Healthier Healthcare ETF?
    etfdb.com

    Looking for a Healthier Healthcare ETF?

    The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs.

  • Corient Capital Partners, LLC Buys Snowflake Inc, Enbridge Inc, Thomson Reuters Corp, Sells General Electric Co, Boeing Co, Uber...
    gurufocus.com

    Corient Capital Partners, LLC Buys Snowflake Inc, Enbridge Inc, Thomson Reuters Corp, Sells General Electric Co, Boeing Co, Uber Technologies Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Thompson Investment Management, Inc. Buys Viatris Inc, Discovery Inc, Kimberly-Clark Corp, Sells General Electric Co, Darden Restaurants...
    gurufocus.com

    Thompson Investment Management, Inc. Buys Viatris Inc, Discovery Inc, Kimberly-Clark Corp, Sells General Electric Co, Darden Restaurants Inc, Sysco Corp

    GuruFocus Article or News written by insider and the topic is about:

  • Global Anti-Obesity Drugs Markets, 2021-2026: Focus On Peripherally & Centrally Acting Drugs, Monotherapies, Polytherapies
    thestreet.com

    Global Anti-Obesity Drugs Markets, 2021-2026: Focus On Peripherally & Centrally Acting Drugs, Monotherapies, Polytherapies

    DUBLIN, Aug. 23, 2021 /PRNewswire/ — The “Global Anti-Obesity Drugs Market (2021-2026) by Drug Type, Drug Class, Medication, Distribution Channel, Geography,

  • Global Equities: Playing Defense
    investing.com

    Global Equities: Playing Defense

    Stocks Analysis by Mike Zaccardi, CFA, CMT covering: S&P 500, US Small Cap 2000, Merck & Company Inc, Pfizer Inc. Read Mike Zaccardi, CFA, CMT's latest article on Investing.com

  • Blackhawk Capital Partners LLC. Buys iShares 1-3 Year Treasury Bond ETF, Schwab Short-Term U.S. Treasury ETF, Adobe Inc, Sells First Trust...
    gurufocus.com

    Blackhawk Capital Partners LLC. Buys iShares 1-3 Year Treasury Bond ETF, Schwab Short-Term U.S. Treasury ETF, Adobe Inc, Sells First Trust TCW Opportunistic Fixed Income ETF, SPDR MSCI ACWI ex-US ETF,

    GuruFocus Article or News written by insider and the topic is about:

  • Parnassus Investments Buys Nike Inc, Alphabet Inc, Gilead Sciences Inc, Sells Amazon.com Inc, Micron Technology Inc, Deere
    gurufocus.com

    Parnassus Investments Buys Nike Inc, Alphabet Inc, Gilead Sciences Inc, Sells Amazon.com Inc, Micron Technology Inc, Deere

    GuruFocus Article or News written by insider and the topic is about:

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    markets.businessinsider.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    SAN FRANCISCO, Aug. 20, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    prnewswire.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Aktueller Marktüberblick vom 20.08.2021
    finanzen.net

    Aktueller Marktüberblick vom 20.08.2021

    Dollar im Rallymodus | Die wichtigsten Daten zu Indizes, Aktien- und Rohstoffmärkten kurz zusammengefasst. Jetzt lesen!

  • Hektischer Handelstag im DAX
    finanzen.net

  • Werewolf (HOWL) Up on Deal With Merck for Solid Tumor Study
    zacks.com

    Werewolf (HOWL) Up on Deal With Merck for Solid Tumor Study

    Werewolf Therapeutics (HOWL) inks a collaboration and supply agreement with Merck to evaluate its candidate, WTX-124, in combination with Keytruda, for treating solid tumors. Stock up.

  • Global Intranasal Drug Delivery Market Forecast to 2027: Burgeoning Geriatric Populace Spurs Growing Demand
    prnewswire.com

    Global Intranasal Drug Delivery Market Forecast to 2027: Burgeoning Geriatric Populace Spurs Growing Demand

    /PRNewswire/ — The

  • Global Intranasal Drug Delivery Market Forecast To 2027: Burgeoning Geriatric Populace Spurs Growing Demand
    thestreet.com

    Global Intranasal Drug Delivery Market Forecast To 2027: Burgeoning Geriatric Populace Spurs Growing Demand

    DUBLIN, Aug. 19, 2021 /PRNewswire/ — The

  • Adagene : Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with...
    marketscreener.com

    Adagene : Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA®(pembrolizumab) (Form 6-K)

    Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137
    Agonist, ADG106, in Combination Therapy with KEYTRUDA®

    -Collaboration to… | August 19, 2021

  • Adagene : Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with...
    marketscreener.com

    Adagene : Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA®(pembrolizumab)

    Collaboration to evaluate NEObody™ product candidate, ADG106, in combination with KEYTRUDA® for patients with advanced or metastatic solid and/or hematological… | August 19, 2021

  • Will The Gains Continue For Johnson & Johnson Stock After A 7% Rise In A Month?
    forbes.com

    Will The Gains Continue For Johnson & Johnson Stock After A 7% Rise In A Month?

    The stock price of Johnson & Johnson (NYSE: JNJ) has seen a rise of over 7% over the last twenty-one trading days, and it is also up 15% year-to-date. Note that such a move for JNJ stock is uncommon, and it has occurred less than 90 times over the last 10 years…

  • Perpetual Investment Management Limited Buys Merck Inc, JB Hunt Transport Services Inc, Vertiv Holdings Co, Sells Amerco Inc, Phillips 66,...
    gurufocus.com

    Perpetual Investment Management Limited Buys Merck Inc, JB Hunt Transport Services Inc, Vertiv Holdings Co, Sells Amerco Inc, Phillips 66, SeaWorld Entertainment Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Rokos Capital Management LLP Buys Alibaba Group Holding, Bristol-Myers Squibb Company, Merck Inc, Sells Amazon.com Inc, Visa Inc, Alphabet...
    gurufocus.com

    Rokos Capital Management LLP Buys Alibaba Group Holding, Bristol-Myers Squibb Company, Merck Inc, Sells Amazon.com Inc, Visa Inc, Alphabet Inc

    GuruFocus Article or News written by insider and the topic is about:

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Entdecke die 6 ETFs in denen Merck & Co. am höchsten gewichtet ist Insgesamt in 31 ETFs enthalten

Dir gefallen die Informationen zu Merck & Co.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Merck & Co.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Merck & Co.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Merck & Co.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba